Is MTALF or JNJ a better dividend investment in 2026?

MTALF currently yields 1886.79% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: MTALF offers higher current income.

What is the dividend yield difference between MTALF and JNJ?

MTALF has a forward dividend yield of 1886.79% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 1883.43 percentage points.

Home › Compare › MTALF vs JNJ

MTALF vs JNJ: Dividend Comparison 2026

MTALF yields 1886.79% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MTALF wins by $5782990267.23M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MTALF

● Live price

1886.79%

Share price

$0.11

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5782990267.25M

Annual income

$5,236,987,112,962,672.00

Full MTALF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — MTALF vs JNJ

📍 MTALF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MTALF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MTALF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MTALF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTALF

Annual income on $10K today (after 15% tax)

$160,377.36/yr

After 10yr DRIP, annual income (after tax)

$4,451,439,046,018,271.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, MTALF beats the other by $4,451,439,046,017,567.50/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTALF + JNJ for your $10,000?

MTALF: 50%JNJ: 50%

100% JNJ50/50100% MTALF

Portfolio after 10yr

$2891495133.64M

Annual income

$2,618,493,556,481,750.00/yr

Blended yield

90.56%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MTALF

No analyst data

Altman Z

14.9

Piotroski

1/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTALF buys

JNJ buys

No recent congressional trades found for MTALF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMTALFJNJ

Forward yield	1886.79% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$5782990267.25M ✓	$20.0K
Annual income after 10y	$5,236,987,112,962,672.00 ✓	$827.78
Total dividends collected	$5744057059.85M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: MTALF vs JNJ ($10,000, DRIP)

Year	MTALF Portfolio	MTALF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$199,379	$188,679.25	$10,676	$355.77	+$188.7K → MTALF
2	$3,729,105	$3,515,768.74	$11,407	$389.39	+$3.72M → MTALF
3	$65,445,695	$61,455,553.23	$12,198	$426.53	+$65.43M → MTALF
4	$1,078,011,459	$1,007,984,564.96	$13,056	$467.62	+$1078.00M → MTALF
5	$16,670,637,928	$15,517,165,667.35	$13,987	$513.12	+$16670.62M → MTALF
6	$242,100,496,658	$224,262,914,074.44	$14,998	$563.56	+$242100.48M → MTALF
7	$3,302,854,764,063	$3,043,807,232,639.23	$16,098	$619.52	+$3302854.75M → MTALF
8	$42,342,581,990,045	$38,808,527,392,498.28	$17,295	$681.69	+$42342581.97M → MTALF
9	$510,283,321,767,048	$464,976,759,037,699.75	$18,599	$750.82	+$510283321.75M → MTALF
10	$5,782,990,267,253,413	$5,236,987,112,962,672.00	$20,022	$827.78	+$5782990267.23M → MTALF

MTALF vs JNJ: Complete Analysis 2026

MTALF — Stock

Metallica Metals Corp. operates as a junior exploration company that explores for gold, silver, platinum, and palladium properties. Its flagship asset is the Starr project located in the Shebandowan Greenstone Belt, Ontario. It also holds 100% interest in the Richview Pine Project and the Sammy RidgeLine Project located in Northwestern Ontario. The company was formerly known as Cameo Industries Corp. and changed its name to Metallica Metals Corp. in December 2020. Metallica Metals Corp. was incorporated in 1987 and is based in Vancouver, Canada.

Full MTALF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this MTALF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTALF vs SCHD MTALF vs JEPI MTALF vs O MTALF vs KO MTALF vs MAIN MTALF vs ABBV MTALF vs MRK MTALF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.